HCV-RNA (b-DNA)

sustained responder to therapy

sustained non-responder

No.

total

No.

total

At week 4

<615 IU/ml

21/24 (87.5%)

41/57

(72%)

3/24 (12.5%)

16/57

(28.1%)

>615 IU/ml

20/33 (60.6%)

13/33 (39.4%)

At week 12

<615 IU/ml

35/45 (77.7%)

45/57

(78.9%)

10/45 (22.2%)

16/57

(28.1%)

>615 IU/ml

6/12 (50%)

6/12 (50%)